Skip to main content
. 2020 Jan 10;9(1):188. doi: 10.3390/jcm9010188

Figure 3.

Figure 3

Longitudinal follow-up of the CTC counts for monitoring the disease status of patients with HCC (part I). (AC) The blood samples were longitudinally collected from patients #1 (panel A), #17 (panel B), and #19 (panel C), who had a high initial serum AFP level followed by a decrease. Series testing of the CTC count and the serum AFP level were performed and plotted accordingly. The disease status (SD, PR, and PD) was determined and was used as an indicator of the patient’s clinical outcome.